| Company/Division name | Vibalogics GMP |
| Parent company | DPS Group |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 150 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Boxborough |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | viral vector gene therapy, vaccines |
| What domestic positive factors made reshoring more attractive? | Automation/technology |
